Literature DB >> 31444805

Long-term outcomes in treated males with anorexia nervosa and bulimia nervosa-A prospective, gender-matched study.

Christine Strobel1, Norbert Quadflieg2, Silke Naab1, Ulrich Voderholzer1, Manfred M Fichter1,2.   

Abstract

OBJECTIVE: We report on the long-term outcome of males compared to females treated for anorexia nervosa (AN) or bulimia nervosa (BN).
METHODS: A total of 119 males with AN and 60 males with BN were reassessed 5.8 ± 4.6 and 7.5 ± 5.9 years (respectively) after treatment and compared to matched female patients.
RESULTS: At follow-up, males with AN had a higher body weight than females. For AN, remission rates (40% males vs. 41% females) did not differ at follow-up. And at follow-up, more males (34%) than females (19%) had an eating disorder not otherwise specified (ED-NOS; p < .01). At follow-up of AN, there was no binge-eating disorder (BED) and obesity was rare. For BN, remission rates (44% males vs. 50% females) and frequency of AN, BN, BED and ED-NOS did not differ at follow-up. Males with AN scored lower than females at follow-up on most subscales of the Eating Disorder Inventory (EDI) and on somatization, obsessive-compulsive symptoms, and depression (Brief Symptom Inventory). Males with BN scored lower than females with BN on perfectionism and higher on interpersonal distrust (EDI) at follow-up. DISCUSSION: Results from the scarce literature on males with ED are inconclusive regarding longer term outcome. In the present study, males with AN showed a slightly better outcome than females. In BN, outcome was about the same in males and females. According to our study, existing treatment is equally effective in both males and females. Additional research on the need of gender-specific diagnosis and therapy is required.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  anorexia nervosa; bulimia nervosa; course; eating disorder; females; long-term; males; outcome

Mesh:

Year:  2019        PMID: 31444805     DOI: 10.1002/eat.23151

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  7 in total

Review 1.  Eating disorders in adolescent boys and young men: an update.

Authors:  Jason M Nagata; Kyle T Ganson; Stuart B Murray
Journal:  Curr Opin Pediatr       Date:  2020-08       Impact factor: 2.856

2.  Gender Differences in Treatment Outcomes for Eating Disorders: A Case-Matched, Retrospective Pre-Post Comparison.

Authors:  Georg Halbeisen; Karsten Braks; Thomas J Huber; Georgios Paslakis
Journal:  Nutrients       Date:  2022-05-27       Impact factor: 6.706

3.  Inhibition of POMC neurons in mice undergoing activity-based anorexia selectively blunts food anticipatory activity without affecting body weight or food intake.

Authors:  Caitlin M Daimon; Shane T Hentges
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-01-19       Impact factor: 3.619

4.  Detection, treatment, and course of eating disorders in Finland: A population-based study of adolescent and young adult females and males.

Authors:  Yasmina Silén; Pyry N Sipilä; Anu Raevuori; Linda Mustelin; Mauri Marttunen; Jaakko Kaprio; Anna Keski-Rahkonen
Journal:  Eur Eat Disord Rev       Date:  2021-05-18

5.  A Plea for Diversity in Eating Disorders Research.

Authors:  Georg Halbeisen; Gerrit Brandt; Georgios Paslakis
Journal:  Front Psychiatry       Date:  2022-02-18       Impact factor: 4.157

6.  Predictors of illness course and health maintenance following inpatient treatment among patients with anorexia nervosa.

Authors:  Deborah R Glasofer; Alexandra F Muratore; Evelyn Attia; Peng Wu; Yuanjia Wang; Hillary Minkoff; Teresa Rufin; B Timothy Walsh; Joanna E Steinglass
Journal:  J Eat Disord       Date:  2020-12-02

Review 7.  Alliance matters: but how much? A systematic review on therapeutic alliance and outcome in patients with anorexia nervosa and bulimia nervosa.

Authors:  Janina Werz; Ulrich Voderholzer; Brunna Tuschen-Caffier
Journal:  Eat Weight Disord       Date:  2021-08-10       Impact factor: 3.008

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.